Bausch Health Companies I...

AI Score

0

Unlock

6.33
-0.12 (-1.86%)
At close: Feb 10, 2025, 3:59 PM
6.32
-0.16%
After-hours Feb 10, 2025, 07:00 PM EST
undefined%
Bid 6.12
Market Cap 2.33B
Revenue (ttm) -
Net Income (ttm) -
EPS (ttm) -0.48
PE Ratio (ttm) -13.19
Forward PE n/a
Analyst Hold
Ask 6.7
Volume 1,322,573
Avg. Volume (20D) 2,138,203
Open 6.43
Previous Close 6.45
Day's Range 6.19 - 6.45
52-Week Range 3.96 - 11.46
Beta undefined

About BHC

Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment offers products with a focus on...

Sector Healthcare
IPO Date Mar 29, 1994
Employees 20,270
Stock Exchange NYSE
Ticker Symbol BHC

Analyst Forecast

According to 5 analyst ratings, the average rating for BHC stock is "Hold." The 12-month stock price forecast is $8, which is an increase of 26.38% from the latest price.

Buy 0.00%
Hold 80.00%
Sell 20.00%
Stock Forecasts

Next Earnings Release

Bausch Health Companies Inc. is scheduled to release its earnings on Feb 19, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
4 days ago
-10.9%
Bausch Health shares are trading lower after the c... Unlock content with Pro Subscription
3 months ago
+6.3%
Bausch Health Companies shares are trading higher after RBC Capital raised its price target on the stock from $10 to $11.